Clinical evaluation of the effect of Siddha classical drug VALLARAI ILAGAM and KARAPPAN POOSU ENNAI for the treatment of SKIN ITCHING.

Clinical evaluation of the effect of VALLARAI ILAGAM and KARAPPAN POOSU ENNAI for the treatment of MANDAI KARAPPAN.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/12/022405

Enrollment

Registered

2019-12-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L218- Other seborrheic dermatitis

Interventions

Intervention1: vallÄ?rai iá¸·akam: Should be administrated orally two times a day after food for a period of 21 days Dose : 1-2gram. Intervention2: karappÄ?nÌ± pÅ«cu eá¹?á¹?ey: Should be applied exter

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with any of the following symptoms will be included in the study 1.Severe Itching 2.Erythema 3.Vesicles 4.Oozing 5.Linchenification Subject should be ready to comply with the treatment protocols.

Exclusion criteria

Exclusion criteria: Subject with 1.Age below 2 years & above 12 years 2.Any adverse reaction 3.Furunculosis 4.Eczema due to contact dermatitis 5.Idiosyncrasy Will be excluded from the study.

Design outcomes

Primary

Measure	Time frame
Reduction of Scaling, Ertheyma, Papules, Vesiculation, Oozing.Timepoint: 15 Days	—

Secondary

Measure	Time frame
ESR Total Eosinophil CountTimepoint: 21 Days	—

Countries

India

Contacts

Public ContactSoundararajan D K

Government siddha medical college and hospital

dr.dks.2012@gmail.com9442048801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026